SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-139976
Filing Date
2024-05-16
Accepted
2024-05-16 06:40:50
Documents
4
Period of Report
2024-06-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d929103ddef14a.htm DEF 14A 356920
2 GRAPHIC g929103g00a11.jpg GRAPHIC 243944
3 GRAPHIC g929103g00a22.jpg GRAPHIC 215115
4 GRAPHIC g929103g15p03.jpg GRAPHIC 39934
  Complete submission text file 0001193125-24-139976.txt   1045917
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Therapeutics, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39856 | Film No.: 24953525
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)